Titre : Psychoses toxiques

Psychoses toxiques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Case-Control Studies
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Psychoses toxiques : Questions médicales les plus fréquentes", "headline": "Psychoses toxiques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Psychoses toxiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-10", "dateModified": "2025-03-05", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Psychoses toxiques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Troubles liés à une substance", "url": "https://questionsmedicales.fr/mesh/D019966", "about": { "@type": "MedicalCondition", "name": "Troubles liés à une substance", "code": { "@type": "MedicalCode", "code": "D019966", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.900" } } }, "about": { "@type": "MedicalCondition", "name": "Psychoses toxiques", "alternateName": "Psychoses, Substance-Induced", "code": { "@type": "MedicalCode", "code": "D011605", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Carsten Hjorthøj", "url": "https://questionsmedicales.fr/author/Carsten%20Hjorth%C3%B8j", "affiliation": { "@type": "Organization", "name": "Copenhagen Research Center for Mental Health-CORE, Mental Health Center Copenhagen, Copenhagen University Hospital, Copenhagen (Hjorthøj, Starzer, Benros, Nordentoft); Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH) (Hjorthøj, Benros, Nordentoft); and Section of Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen (Hjorthøj)." } }, { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Manuel J Cuesta", "url": "https://questionsmedicales.fr/author/Manuel%20J%20Cuesta", "affiliation": { "@type": "Organization", "name": "Navarrabiomed and Instituto de Investigación Sanitaria de Navarra (IdISNa) Spain; Psychiatry Service, Complejo Hospitalario de Navarra Spain." } }, { "@type": "Person", "name": "Merete Nordentoft", "url": "https://questionsmedicales.fr/author/Merete%20Nordentoft", "affiliation": { "@type": "Organization", "name": "Copenhagen Research Center for Mental Health-CORE, Mental Health Center Copenhagen, Copenhagen University Hospital, Copenhagen (Hjorthøj, Starzer, Benros, Nordentoft); Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH) (Hjorthøj, Benros, Nordentoft); and Section of Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen (Hjorthøj)." } }, { "@type": "Person", "name": "Heidi Taipale", "url": "https://questionsmedicales.fr/author/Heidi%20Taipale", "affiliation": { "@type": "Organization", "name": "Niuvanniemi Hospital, Kuopio, Finland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Determinants of Neonatal Mortality in Bhutan: A Case-Control Study.", "datePublished": "2023-10-16", "url": "https://questionsmedicales.fr/article/37842840", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/10105395231203112" } }, { "@type": "ScholarlyArticle", "name": "Antipsychotic medication use and fracture: a case-control study.", "datePublished": "2023-08-22", "url": "https://questionsmedicales.fr/article/37608079", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-40762-w" } }, { "@type": "ScholarlyArticle", "name": "Oral hygiene and infective endocarditis: a case control study.", "datePublished": "2023-03-11", "url": "https://questionsmedicales.fr/article/37085335", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.oooo.2023.02.020" } }, { "@type": "ScholarlyArticle", "name": "Respiratory muscle strength in stroke: a case-control study.", "datePublished": "2024-08-16", "url": "https://questionsmedicales.fr/article/39166672", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/1806-9282.20240061" } }, { "@type": "ScholarlyArticle", "name": "The Association between Allergy and Cancer: A Case-Control Study.", "datePublished": "2024-08-01", "url": "https://questionsmedicales.fr/article/39205576", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.31557/APJCP.2024.25.8.2787" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Troubles mentaux", "item": "https://questionsmedicales.fr/mesh/D001523" }, { "@type": "ListItem", "position": 3, "name": "Troubles liés à une substance", "item": "https://questionsmedicales.fr/mesh/D019966" }, { "@type": "ListItem", "position": 4, "name": "Psychoses toxiques", "item": "https://questionsmedicales.fr/mesh/D011605" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Psychoses toxiques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Psychoses toxiques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Psychoses toxiques", "description": "Comment diagnostiquer une psychose toxique ?\nQuels tests sont utilisés pour le diagnostic ?\nLes psychoses toxiques sont-elles réversibles ?\nQuels critères DSM sont utilisés ?\nComment différencier d'autres psychoses ?", "url": "https://questionsmedicales.fr/mesh/D011605?mesh_terms=Case-Control+Studies&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Psychoses toxiques", "description": "Quels sont les symptômes courants ?\nLes symptômes varient-ils selon la substance ?\nPeut-on avoir des symptômes physiques ?\nLes symptômes sont-ils immédiats ?\nY a-t-il des symptômes psychologiques persistants ?", "url": "https://questionsmedicales.fr/mesh/D011605?mesh_terms=Case-Control+Studies&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Psychoses toxiques", "description": "Comment prévenir les psychoses toxiques ?\nLes programmes de sensibilisation sont-ils efficaces ?\nLe soutien familial aide-t-il ?\nLes groupes de soutien sont-ils utiles ?\nLes politiques publiques jouent-elles un rôle ?", "url": "https://questionsmedicales.fr/mesh/D011605?mesh_terms=Case-Control+Studies&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Psychoses toxiques", "description": "Quel est le traitement principal ?\nDes médicaments sont-ils utilisés ?\nLa thérapie est-elle efficace ?\nCombien de temps dure le traitement ?\nY a-t-il des traitements alternatifs ?", "url": "https://questionsmedicales.fr/mesh/D011605?mesh_terms=Case-Control+Studies&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Psychoses toxiques", "description": "Quelles complications peuvent survenir ?\nLes psychoses toxiques augmentent-elles le risque de suicide ?\nY a-t-il des risques de dépendance ?\nLes complications sont-elles réversibles ?\nLes complications affectent-elles la vie quotidienne ?", "url": "https://questionsmedicales.fr/mesh/D011605?mesh_terms=Case-Control+Studies&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Psychoses toxiques", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLe stress joue-t-il un rôle ?\nLes troubles mentaux préexistants augmentent-ils le risque ?\nLes environnements sociaux influencent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D011605?mesh_terms=Case-Control+Studies&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une psychose toxique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'usage de substances et l'évaluation des symptômes." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des évaluations psychologiques peuvent être effectués." } }, { "@type": "Question", "name": "Les psychoses toxiques sont-elles réversibles ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être réversibles avec l'arrêt de la substance et un traitement approprié." } }, { "@type": "Question", "name": "Quels critères DSM sont utilisés ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les critères DSM-5 incluent des symptômes psychotiques liés à l'usage de substances." } }, { "@type": "Question", "name": "Comment différencier d'autres psychoses ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Il faut évaluer l'historique d'usage de substances et l'absence d'autres causes." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent hallucinations, délires, agitation et désorientation." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la substance ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon la substance utilisée et la dose." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes physiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes physiques comme des tremblements ou des nausées peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes sont-ils immédiats ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent apparaître rapidement après la consommation ou après un sevrage." } }, { "@type": "Question", "name": "Y a-t-il des symptômes psychologiques persistants ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes psychologiques peuvent persister même après l'arrêt de la substance." } }, { "@type": "Question", "name": "Comment prévenir les psychoses toxiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par l'éducation sur les risques liés à l'usage de substances." } }, { "@type": "Question", "name": "Les programmes de sensibilisation sont-ils efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les programmes de sensibilisation peuvent réduire l'usage de substances et les risques." } }, { "@type": "Question", "name": "Le soutien familial aide-t-il ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Un soutien familial solide peut aider à prévenir l'usage de substances et les troubles associés." } }, { "@type": "Question", "name": "Les groupes de soutien sont-ils utiles ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les groupes de soutien offrent un environnement pour partager des expériences et des conseils." } }, { "@type": "Question", "name": "Les politiques publiques jouent-elles un rôle ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des politiques publiques sur la santé mentale et la toxicomanie peuvent réduire les cas." } }, { "@type": "Question", "name": "Quel est le traitement principal ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est l'arrêt de la substance et la prise en charge des symptômes." } }, { "@type": "Question", "name": "Des médicaments sont-ils utilisés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antipsychotiques peuvent être prescrits pour gérer les symptômes psychotiques." } }, { "@type": "Question", "name": "La thérapie est-elle efficace ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie comportementale peut aider à traiter les causes sous-jacentes et les comportements." } }, { "@type": "Question", "name": "Combien de temps dure le traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La durée du traitement varie, mais peut durer plusieurs semaines à plusieurs mois." } }, { "@type": "Question", "name": "Y a-t-il des traitements alternatifs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des approches comme la méditation ou le soutien psychologique peuvent être bénéfiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles mentaux chroniques, des problèmes de santé physique." } }, { "@type": "Question", "name": "Les psychoses toxiques augmentent-elles le risque de suicide ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles augmentent le risque de comportements suicidaires et d'automutilation." } }, { "@type": "Question", "name": "Y a-t-il des risques de dépendance ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'usage de substances peut entraîner une dépendance et des rechutes fréquentes." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié et un suivi." } }, { "@type": "Question", "name": "Les complications affectent-elles la vie quotidienne ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent gravement affecter la vie quotidienne, les relations et le travail." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'usage de substances, des antécédents familiaux de troubles mentaux." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes adultes sont plus susceptibles de développer des psychoses toxiques." } }, { "@type": "Question", "name": "Le stress joue-t-il un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut augmenter le risque de développer des troubles liés à l'usage de substances." } }, { "@type": "Question", "name": "Les troubles mentaux préexistants augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes avec des troubles mentaux préexistants sont à risque accru." } }, { "@type": "Question", "name": "Les environnements sociaux influencent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des environnements sociaux défavorables peuvent augmenter le risque d'usage de substances." } } ] } ] }

Sources (10000 au total)

Oral hygiene and infective endocarditis: a case control study.

To determine if oral hygiene is associated with infective endocarditis (IE) among those at moderate risk for IE.... This is a case control study of oral hygiene among hospitalized patients with IE (cases) and outpatients with heart valve disease but without IE (controls). The primary outcome was the mean dental cal... The 62 case participants had 53% greater mean dental calculus index than the 119 control participants (0.84, 0.55, respectively; difference = 0.29, 95% CI: 0.11, 0.48; P = .002) and 26% greater mean d... These data provide evidence to support and strengthen current American Heart Association guidance that those at risk for IE can reduce potential sources of IE-related bacteremia by maintaining optimal...

Respiratory muscle strength in stroke: a case-control study.

The aim of the study was to determine the respiratory muscle strength of stroke patients and compare them with healthy individuals.... The study was conducted with 171 patients who had a stroke between 2017 and 2021 and 32 healthy controls. Respiratory muscle strength and inspiratory and expiratory mouth pressure (MIP and MEP) were m... The stroke group exhibited significantly lower values in both MIP for men (p<0.001) and women (p=0.013) and maximal expiratory pressure for men (p<0.001) and women (p=0.042), compared with the healthy... This study highlights the significant respiratory muscle weakness experienced by stroke patients, with gender-specific differences. It highlights the importance of incorporating respiratory assessment...

The Association between Allergy and Cancer: A Case-Control Study.

Allergies may either have a protective or a promoting effect on cancers. This study seeks to explore the relationship between various types of allergies and three specific cancer types: lung, breast, ... Among the 556 patients, there were 115 cases of colorectal cancer, 305 cases of breast cancer, and 136 cases of lung cancer. The ratio of the case group to the control group was 1:1. We assessed the a... The results showed a protective association between itching or urticaria due to environmental factors and colorectal cancer (adjusted odds ratio [AOR]: 0.4, 95% CI: 0.17-0.94), as well as lung cancer ... allergies and cancer have a site-specific assciation . To confirm these findings and understand the reasons behind these associations, more investigation is required....

Random forests for the analysis of matched case-control studies.

Conditional logistic regression trees have been proposed as a flexible alternative to the standard method of conditional logistic regression for the analysis of matched case-control studies. While the... A random forest method for the analysis of matched case-control studies based on conditional logistic regression trees is proposed, which overcomes the issue of high variability. It provides an accura... The proposed random forest method is a promising add-on to the toolbox for the analysis of matched case-control studies and addresses the need for machine-learning methods in this field. It provides a...

Factors associated with premature birth: a case-control study.

To analyze the socioeconomic, demographic, environmental, reproductive, behavioral, and health-care factors associated with preterm birth.... Case-control study, with case group composed of preterm infants and the control group by full term live births. Each case was paired with two controls according to sex and date of birth. Interviews we... 221 live births were allocated in the case group and 442 in the control group. After analysis adjusted for other factors under study, the highest chances of prematurity were associated with being the ... The factors associated with a higher chance of prematurity were: higher family income, previous preterm child, primiparity, violence against pregnant women and cesarean section. Having attended more t...

Multiple sclerosis and autoimmune diseases - a case control study.

Multiple sclerosis (MS) is one of the most common autoimmune diseases worldwide, and various autoimmune comorbidities have been reported with MS. The aim of this study was to estimate the prevalence o... In this retrospective multicentre study, we investigated a group of patients with MS, and their relatives, in terms of age, gender, and the presence of simultaneous autoimmune diseases such as Graves'... This study included 381 patients with MS, of whom 52.23% were women. 27 patients (7.09%) had at least one autoimmune disease. The most common comorbidity was Hashimoto's thyroiditis (14 patients). 77 ... Our study revealed that the probability of autoimmune diseases co-occurring in patients with MS, and in their relatives, is higher and we found the greatest risk to be for Hashimoto's thyroiditis....

Diagnostic approach to monkeypox outbreak, a case-control study.

An international outbreak of the monkeypox (MPX) virus is ongoing with a different clinical presentation than previously reported.... A monocentric retrospective study was designed to investigate clinical predictors of confirmed MPX cases among a group of patients referred for MPX screening. Furthermore, the additional value of perf... Between 28/05/2022 and 22/07/2022, the medical records of patients referred for MPX screening were investigated. Patients with positive RT-PCR were defined as cases, while the ones with negative RT-PC... Among the 141 included patients, 85 (60%) had at least one positive RT-PCR for MPX. Carrying out RT-PCR only on the swab obtained by skin lesion sampling, 7 patients (7/85: 8%) would have been misdiag... MPX diagnosis was associated with being MSM, living with HIV, having multiple sexual partners, and presenting with anogenital skin lesions. In this study, the derived score had good sensitivity and sp...